Drugs / Ypeginterferon alfa-2a
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01343186 | Jan → May 2011 | — | Xiamen Amoytop Biotech Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ypeginterferon alfa-2a | “s,c, 45mcg of Ypeginterferon alfa-2a” NCT01343186 ↗ |
| Route | Subcutaneous | “s,c, 45mcg of Ypeginterferon alfa-2a” NCT01343186 ↗ |